AU2017904756A0 - Pharmaceutical combinations and methods of treatment - Google Patents

Pharmaceutical combinations and methods of treatment

Info

Publication number
AU2017904756A0
AU2017904756A0 AU2017904756A AU2017904756A AU2017904756A0 AU 2017904756 A0 AU2017904756 A0 AU 2017904756A0 AU 2017904756 A AU2017904756 A AU 2017904756A AU 2017904756 A AU2017904756 A AU 2017904756A AU 2017904756 A0 AU2017904756 A0 AU 2017904756A0
Authority
AU
Australia
Prior art keywords
treatment
methods
pharmaceutical combinations
pharmaceutical
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017904756A
Inventor
Philip Myers Heyward
Alexander Tups
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otago Innovation Ltd
Original Assignee
Otago Innovation Ltd
Filing date
Publication date
Application filed by Otago Innovation Ltd filed Critical Otago Innovation Ltd
Publication of AU2017904756A0 publication Critical patent/AU2017904756A0/en
Assigned to OTAGO INNOVATION LIMITED reassignment OTAGO INNOVATION LIMITED Request for Assignment Assignors: Heyward, Philip, Tups, Alexander
Priority to PCT/NZ2018/050169 priority Critical patent/WO2019103629A1/en
Priority to JP2020528132A priority patent/JP7434154B2/en
Priority to EP18880166.6A priority patent/EP3713561A4/en
Priority to KR1020207016293A priority patent/KR20200136360A/en
Priority to US15/733,131 priority patent/US11738001B2/en
Priority to AU2018370761A priority patent/AU2018370761A1/en
Priority to MX2020005007A priority patent/MX2020005007A/en
Priority to CA3085758A priority patent/CA3085758A1/en
Priority to CN201880075904.7A priority patent/CN111386111A/en
Abandoned legal-status Critical Current

Links

AU2017904756A 2017-11-24 2017-11-24 Pharmaceutical combinations and methods of treatment Abandoned AU2017904756A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CN201880075904.7A CN111386111A (en) 2017-11-24 2018-11-26 Pharmaceutical combinations and methods of treating diabetes and related disorders
CA3085758A CA3085758A1 (en) 2017-11-24 2018-11-26 Pharmaceutical combinations and methods of treatment
KR1020207016293A KR20200136360A (en) 2017-11-24 2018-11-26 Pharmaceutical combinations for the treatment of diabetes and related disorders and methods of treatment thereof
JP2020528132A JP7434154B2 (en) 2017-11-24 2018-11-26 Pharmaceutical combinations and methods for treating diabetes and related diseases
EP18880166.6A EP3713561A4 (en) 2017-11-24 2018-11-26 Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders
PCT/NZ2018/050169 WO2019103629A1 (en) 2017-11-24 2018-11-26 Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders
US15/733,131 US11738001B2 (en) 2017-11-24 2018-11-26 Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders
AU2018370761A AU2018370761A1 (en) 2017-11-24 2018-11-26 Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders
MX2020005007A MX2020005007A (en) 2017-11-24 2018-11-26 Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders.

Publications (1)

Publication Number Publication Date
AU2017904756A0 true AU2017904756A0 (en) 2017-12-07

Family

ID=

Similar Documents

Publication Publication Date Title
EP3681479A4 (en) Method of administration and treatment
EP3454945A4 (en) Ash1l inhibitors and methods of treatment therewith
EP3370748A4 (en) Therapeutic microbiota for the treatment and/or prevention of food allergy
EP3399902A4 (en) One-operator surgical system and methods of use
EP3371306B8 (en) Materials and methods for treatment of hemoglobinopathies
EP3487379A4 (en) Medical devices and methods of use
EP3303634A4 (en) Cas9 variants and methods of use thereof
EP3426250A4 (en) Methods of treatment
EP3554401A4 (en) Ocular treatment devices and related methods of use
EP3437637A4 (en) Pharmaceutical preparation of palbociclib and preparation method thereof
EP3551033A4 (en) Endoscope and method of use
EP3442515A4 (en) Liposomal preparation and methods of treatment
EP3341391A4 (en) Compositions and methods for treatment of pain
EP3694832A4 (en) Extended release pharmaceutical formulation and methods of treatment
EP3706736A4 (en) Ash1l degraders and methods of treatment therewith
EP3526205A4 (en) Therapeutic compounds and methods of use thereof
EP3630175A4 (en) Methods and devices for the treatment of food allergies
EP3496804A4 (en) Bioelectric devices and methods of use
EP3635000A4 (en) Manabodies and methods of using
EP3713583A4 (en) Methods and compositions for treatment of skin
EP3490476A4 (en) Devices and methods for treatment of skin conditions
EP3313427A4 (en) Therapeutic peptides and methods of use thereof
EP3691748A4 (en) Acetaminophen-pregabalin combinations and methods of treating pain
EP3599983A4 (en) Endoscopes and methods of treatment
EP3458062A4 (en) Treatment of pain